title: Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.
abstract: Previous experiments in mice showed that dietary trans-fats could play a role in non-alcoholic steatohepatitis (NASH) yet little is known about the accumulation trans-fats in hepatic lipid pools in relationship to liver injury. NASH is also associated with obesity yet improves with only modest weight loss. To distinguish the role of obesity versus sustained consumption of a trans-fat containing diet in causing NASH, mice with obesity and NASH induced by consuming a high trans-fat diet for 16 weeks were subsequently fed standard chow or maintained on trans-fat chow for another 8 weeks. The accumulation, partitioning and loss of trans-fats in the major hepatic lipid pools during and after trans-fat consumption were determined. Obese mice switched to standard chow remained obese but steatohepatitis improved. trans-fats were differentially incorporated into the major hepatic lipid pools and the loss of trans-fats after crossover to control chow was greatest in the cholesteryl ester pool. In summary, dietary changes can improve the biochemical and histopathological changes of NASH despite persistent obesity in mice. Analysis of hepatic lipids confirmed that dietary trans-fats accumulate in the major lipid pools and are released differentially with diet normalization. The substantial loss of trans-fats from the cholesteryl ester pool in parallel with improvement in NASH suggests that this pool of trans-fats could play a role in the pathogenesis of NASH.
authors.affiliation: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University, Saint Louis, USA. tetriba@slu.edu
authors.forename: Brent A
authors.initials: BA
authors.lastname: Neuschwander-Tetri
authors.forename: David A
authors.initials: DA
authors.lastname: Ford
authors.forename: Sahaja
authors.initials: S
authors.lastname: Acharya
authors.forename: George
authors.initials: G
authors.lastname: Gilkey
authors.forename: Metin
authors.initials: M
authors.lastname: Basaranoglu
authors.forename: Laura H
authors.initials: LH
authors.lastname: Tetri
authors.forename: Elizabeth M
authors.initials: EM
authors.lastname: Brunt
mesh_terms: D000818:Animals; D002788:Cholesterol Esters / Q000378:metabolism; D004041:Dietary Fats / Q000009:adverse effects; D005234:Fatty Liver / Q000139:chemically induced* / Q000473:pathology; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D065626:Non-alcoholic Fatty Liver Disease; D044242:Trans Fatty Acids / Q000009:adverse effects*
chemical_list: D002788:Cholesterol Esters; D004041:Dietary Fats; D008055:Lipids; D044242:Trans Fatty Acids